4-demethoxydaunorubicin ( 4-dm dnr ) , a new analog of daunorubicin , was tested at an every 3-week dose schedule in 63 evaluable patients with various forms of disseminated malignancy .
C0020789
4-demethoxydaunorubicin
C0011015
daunorubicin